// // It is highly recommended to set this option, even though it's not required. // defaults to undefined. //appElement: "#page-container", // Optional. You can customize the name of the cookie that Orejime uses for storing // user consent decisions. // defaults to "orejime". cookieName: "diadao_cookies", // Optional. You can set a custom expiration time for the Orejime cookie, in days. // defaults to 365. cookieExpiresAfterDays: 365, // You must provide a link to your privacy policy page privacyPolicy: JSON.parse(Config.orejimePrivacyPolicyPage), // You must provide a link to your cookies policy page cookiePolicy: JSON.parse(Config.orejimeCookiesPage), // Optional. Applications configured below will be ON by default if default=true. // defaults to true default: true, // Optional. If "mustConsent" is set to true, Orejime will directly display the consent // manager modal and not allow the user to close it before having actively // consented or declined the use of third-party apps. // defaults to false mustConsent: false, // Optional. If "implicitConsent" is set to true, Orejime will automatically accept // cookies if the user continues his navigation on the website after the // first page. If you enable this, you must warn the user // of this behavior in the notice window. You can do that easily by overriding // translation strings (see below). // defaults to false implicitConsent: false, // Optional. You can define the UI language directly here. If undefined, Orejime will // use the value given in the global "lang" variable, or fallback to the value // in the lang attribute, or fallback to "en". lang: Config.currentLang, // You can overwrite existing translations and add translations for your // app descriptions and purposes. See `src/translations.yml` for a full // list of translations that can be overwritten // translations: Config.texts.orejime, // If you want to use custom text for your project translations: {}, // The list of third-party apps that Orejime will manage for you. // The apps will appear in the modal in the same order as defined here. // appsList: ["analytics", "big_calendar", "orejime", "offerhighlight"], appsList: JSON.parse(Config.orejimeAppsList), apps: [] }

新闻稿

New product line in oncology: a milestone passed with the signature of a partnership between Intrasense and I-SERIS

5 10 月 2021

Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software
solutions and the medical imaging and radiology group I-SERIS, which includes
the clinics of Clémentville (Montpellier), Clermont l'Hérault and the scanner center
of the Pasteur clinic in Pézenas, announce the signing of an agreement for the
development of the new oncology solution Myra.

发现更多

HY 2021 Consolidated Results Intrasense Group

22 9 月 2021

Intrasense announces its 2021 consolidated IFRS half-year results at Group level as of June 30, 2021.

发现更多

Intrasense participates in the SIFEM 2021 congress from September 17 to 19

14 9 月 2021

Intrasense is pleased to announce its participation in the congress of the Société d'Imagerie de la Femme, in Ajaccio from September 17 to 19.

发现更多

Intrasense provides an update on its development strategy and growth prospects

7 9 月 2021

Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software
solutions and Myrian® designer provides an update on its development strategy
following its successful capital increase in June 2021.

发现更多

Intrasense: successful Rights Issue with €4.9 million raised

22 6 月 2021

Intrasense today announced the success of its capital increase through the issuance of new shares (“New Shares”) with shareholders’ preferential subscription rights, for which subscriptions took place between May 28 and June 15, 2021 (the “Rights Issue”).

发现更多

Intrasense launches a Rights Issue

24 5 月 2021

Intrasense launch a capital increase through the issuance of new shares with shareholders’ preferential subscription rights. 

发现更多

Intrasense announces the publication of the annual financial report

30 4 月 2021

Intrasense today announces the publication of its annual financial report for the financial year ended on December 31, 2020.

发现更多

Intrasense announces the referencing of its Myrian® platform with Vidi, first cooperative network of medical imaging groups in France

8 4 月 2021

Intrasense and Vidi, the leading cooperative network of medical imaging groups in France, signed an agreement on January 30th, 2021 to reference Myrian® solutions.

发现更多

New Myrian platform launch, enriched with many new clinical features dedicated to stroke, breast cancer and cardiovascular pathologies

1 4 月 2021

Intrasense is pleased to present the new version 2.9, with a focus on new clinical features.

发现更多

Intrasense Group consolidated 2020 annual results

23 3 月 2021

Intrasense announces its 2020 IFRS Group consolidated annual results.

发现更多
订阅